Generic Launches

Abbreviated New Drug Applications and 505(b)(2) Applications

Second Quarter

GENERICally Speaking

This Generic Launches chart tracks the date, drug, reference-listed company, applicant, and indications of publicly available drug launches resulting from Abbreviated New Drug Applications and 505(b)(2) Applications.

Reference Listed Drug ANDA Holder Generic Drug Name ANDA
Applicant(s)
Indication Launch Date
Noxafil Merck posaconazole Hikma Used to  prevent serious fungal infections that can spread throughout the body in adults and children 2 years of age and older with a weakened ability to fight infection 4/3/2023
Prolixin Apothecon fluphenazine Upsher Smith Used to treat  schizophrenia and psychotic symptoms such as hallucinations, delusions, and hostility 4/3/2023
Noxafil Merck posaconazole Endo Used to  prevent serious fungal infections that can spread throughout the body in adults and children 2 years of age and older with a weakened ability to fight infection 4/4/2023
Bentyl AbbVie dicyclomine TWi  Used to treat functional bowel disorder and irritable bowel syndrome 4/2023?
K-Tab AbbVie potassium chloride TWi Used for prophylaxis and treatment of hypokalemia in patients for whom dietary management with potassium-rich foods or diuretic dose reduction are insufficient 4/2023?
Combigan AbbVie  brimonidine / timolol Upsher Smith Used to treat increased pressure in the eye caused by glaucoma or a condition called hypertension of the eye 4/13/2023
Depo-Testosterone Pfizer testoterone cypionate Xiromed Used as replacement therapy in the male in conditions associated with symptoms of deficiency or absence of endogenous testosterone    4/13/2023
Argatroban Novartis argatroban Par / Endo Used for prophylaxis or treatment of thrombosis in adult patients with heparin- induced thrombocytopenia (HIT) 4/17/2023
Lexiscan Astellas regadenoson Hikma Is a pharmacologic stress agent indicated for radionuclide myocardial perfusion imaging (MPI) in patients unable to undergo adequate exercise stress 4/17/2023
Daliresp AstraZeneca roflumilast Camber / Hetero Used to reduce the risk of COPD exacerbations in patients with severe COPD associated with chronic bronchitis and a history of exacerbations 4/21/2023
Remodulin United Therapeutics treprostinil Dr. Reddy's Labs Used to treat pulmonary arterial hypertension (PAH)  4/21/2023
Zyflo CR Chiesi zileuton Camber / Hetero Is indicated for the prophylaxis and chronic treatment of asthma in adults and children 12 years of age and older 4/26/2023
Delestrogen Par estradiol valerate Xiromed Used to treat moderate to severe vasomotor symptoms associated with the menopause 5/1/2023
Phernegan Mylan promethazine Camber / Hetero Used to treat allergy symptoms such as itching, runny nose, sneezing, itchy or watery eyes, hives, and itchy skin rashes; also prevents motion sickness, and treats nausea and vomiting or pain after surgery; also used as a sedative or sleep aid 5/3/2023
Lexiscan Astellas regadenoson Dr. Reddy's Labs Is a pharmacologic stress agent indicated for radionuclide myocardial perfusion imaging (MPI) in patients unable to undergo adequate exercise stress 5/5/2023
Syprine Bausch trientine HCl Camber / Hetero Used to treat patients with Wilson’s disease who are intolerant of penicillamine 5/8/2023
Cystadane Recordati betaine anhydrous Eton Used to treat homocystinuria 5/10/2023
Prezista Johnson & Johnson darunavir Teva  Used to treat human immunodeficiency virus (HIV) in children age 3 or above and adults with HIV-1 infection 6/1/2023
Prezista Johnson & Johnson darunavir Lupin Used to treat human immunodeficiency virus (HIV) in children age 3 or above and adults with HIV-1 infection 6/3/2023
Mexitil Boehringer Ingelheim mexiletine HCl Camber / Hetero Used to treat documented ventricular arrhythmias, such as sustained ventricular tachycardia, that, in the judgment of the physician, are life-threatening 6/6/2023
Iressa AstraZeneca gefitinib Apotex Used to treat adult patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) with activating mutations of EGFR-TK 6/14/2023
Treanda Teva  bendamustine  Apotex Used to treat chronic lymphocytic leukemia (CLL) and indolent B-cell non-Hodgkin lymphoma (NHL) that has progressed during or within six months of treatment with rituximab or a rituximab-containing regimen 6/14/2023
Vasostrict Endo vasopressin Fresenius Kabi Used to treat increase blood pressure in adults with vasodilatory shock who remain hypotensive despite fluids and catecholamines 6/14/2023
Vimpat UCB lacosamide Apotex Used to treat partial-onset seizures in patients aged one month and older and as adjunctive therapy in the treatment of primary generalized tonic-clonic seizures in patients aged four years and older 6/14/2023
Dexilant Takeda dexlansoprazole Par / Endo Used to treat erosive esophagitis and heartburn associated with symptomatic non-erosive gastroesophageal reflux disease (GERD) 6/15/2023
Thiamine Fresenius Kabi thiamine HCl Lupin Used to treat thiamine deficiency or beriberi whether of the dry (major symptoms related to the nervous system) or wet (major symptoms related to the cardiovascular system) variety  6/19/2023
Iressa AstraZeneca gefitinib Teva  Used to treat adult patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) with activating mutations of EGFR-TK 6/21/2023
Banzel Eisai rufinamide Lupin Used for the adjunctive treatment of seizures associated with Lennox-Gastaut syndrome in pediatric patients one year of age and older and adults 6/23/2023
Kinevac Bracco Diagnostics sincalide Fresenius Kabi Used to stimulate gallbladder contraction or pancreatic secretion during diagnostic tests, and accelerate fluoroscopy and x-ray examination of the intestinal tract 6/21/2023
Vancocin ANI vancomycin Amneal Used to treat serious or severe infections caused by susceptible strains of methicillin-resistant (beta-lactam-resistant) staphylococci; also indicated for penicillin-allergic patients, for patients who cannot receive or who have failed to respond to other drugs, including the penicillins or cephalosporins, and for infections caused by vancomycin-susceptible organisms that are resistant to other antimicrobial drugs 6/2023?
Noxafil Merck posaconazole Endo / Par Indicated for prophylaxis of invasive Aspergillus and Candida infections in patients who are at high risk of developing these infections due to being severely immunocompromised, such as hematopoietic stem cell transplant (HSCT) recipients with graft-versus-host disease (GVHD) or those with hematologic malignancies with prolonged neutropenia (low white blood cell counts) from chemotherapy. 6/29/2023
Midazolam Inforlife  Midazolam in 0.9% sodium chloride Hikma Used for continuous intravenous infusion for sedation of intubated and mechanically ventilated adult, pediatric, and neonatal patients as a component of anesthesia or during treatment in a critical care setting 6/30/2023

Related Publications

First Quarter
GENERICally Speaking: A Hatch-Waxman Litigation Bulletin
Oren Langer, Christopher Pinahs, Emily Tremblay, and Christine May
March 25, 2024
Endo Ventures Unlimited Co. v. Nexus Pharms. Inc.
GENERICally Speaking Hatch Waxman Bulletin
March 22, 2024
Mallinckrodt plc v. Airgas Therapeutics LLC
GENERICally Speaking Hatch Waxman Bulletin
March 8, 2024
UCB, Inc. v. Mylan Techs. Inc.
GENERICally Speaking Hatch Waxman Bulletin
March 5, 2024
Genentech, Inc. v. Sandoz, Inc.
GENERICally Speaking Hatch Waxman Bulletin
Back to Top